In continuation of our extensive studies on a new anti-MRSA natural alternative to vancomycin, we have recently evaluated the anti-MRSA activities of the components isolated from the root bark of Ulmus davidiana var. japonica, which has traditionally been used to treat infectious diseases in Korea. 4) We herewith report the isolation of an important antibacterial component specifically against MRSA strains from the plant.
Experimental
Extraction and Isolation The root bark of U. davidiana Planch. var. japonica NAKAI were collected in Korea in July 1996 and identified by one (H.H.) of the authors. The dried root bark (2 kg) of this plant was extracted three times with MeOH (8 l) under reflux. The MeOH extract (166 g) in water suspension was partitioned successively with diethyl ether and nBuOH. The residue (17 g) from the ether fraction was chromatographed on a silica gel column using a mixture of n-hexane and ethyl acetate (2 : 3) to afford seven fractions. The fourth fraction (3 g), which showed the highest antibacterial activity (MIC 25 mg/ml) against MRSA, was further chromatographed on a silica gel column using a mixture of CHCl 3 and MeOH (50 : 1) to give the pure antibacterial component (18 mg) as a characteristic dark purple solid.
Antibacterial Activity Assays The antibacterial activity tests of the extract and mansonone F from this species were carried out according to the National Committee for Clinical Laboratory Standards (NCCLS) procedure 5) and MICs were determined by a two-fold serial agar dilution method. The media used for preculture and MIC determination were Mueller-Hinton broth (Difco Laboratories, Detroit, MI, U.S.A.) and Mueller-Hinton agar (Difco), respectively. Overnight cultures were diluted with sterile saline solution to the final bacterial density of 10 7 cfu/ml and each bacterial suspension was inoculated with a replicator (Microplanter, Sakuma, Tokyo, Japan) onto a series of Mueller-Hinton agar plates containing each antibacterial agent. The MIC was defined as the lowest concentration of an antibacterial agent that inhibited the development of visible bacterial growth after incubation for 18 h at 37°C.
Results and Discussion
The fourth fraction among the diethyl ether-soluble portion of an aqueous MeOH extract of U. davidiana var. japonica bark showed outstanding antibacterial activity against Gram-positive bacterial strains compared to the other fractions. An active compound (1) was isolated from the fourth fraction using silica gel column chromatography. Its IR spectrum exhibited absorption bands at 1685 cm Ϫ1 (CϭO), 1600 (olefinic CϭC) and 1580 (aromatic CϭC). The EI-mass spectrum of 1 showed a characteristic peak of ortho-naphthoquinone due to [Mϩ2] ϩ at m/z 242. The 1 H-NMR spectrum suggested the compound to be mansonone F (1), showing signals due to three methyl groups (3H each, s at d 1.92, 2.06, and 2.65). In addition to these signals, a singlet aromatic proton of H-2 (1H, s at d 7.02) and two doublet aromatic protons of H-4 (1H, d, Jϭ8.4 Hz at d 7.41) and H-5 (1H, d, Jϭ8.4 Hz at d 7.35) were observed. Based on these data together with the 13 C-NMR spectrum and mp (219-222°C), the active compound was identified as 1 by comparison of its spectral data with those reported. 6, 7) Among the constituents isolated from this plant, 1 was known to be a phytoalexin which is accumulated in the heartwood of the genus Ulmus in response to infections of plant pathogens. [8] [9] [10] This fact indicates the probability of the antibacterial activity of 1. As expected, a component which has shown exceptionally potent antibacterial activity was identified as 1 of a known sesquiterpenoid quinone. This compound was selected after initial antibacterial activity tests of all the isolated constituents against the Gram-positive and Gram-negative bacterial strains. The other components ex- A highly potent anti-MRSA sesquiterpenoid has been isolated from Ulmus davidiana var. japonica, which has been traditionally used to treat infectious diseases in Korea. This naturally occurring antibiotic was identified as mansonone F (1). This compound has been found to be highly active specifically against MRSA and showed an MIC range of 0.39-3.13 m mg/ml which is comparable to that of vancomycin.
Key words anti-MRSA sesquiterpenoid; Ulmus davidiana var. japonica; mansonone F Fig. 1 . Chemical Structure of Mansonone F (1) cept 1 showed low or no activity against all the bacterial strains tested. Table 1 summarizes the minimal inhibitory concentrations (MICs) of 1 against eight Gram-positive bacterial strains and 29 Gram-negative bacterial strains which are routinely used for evaluation of the efficacy of potential antibacterial substances. Mansonone F specifically showed potent activity against all the Gram-positive bacterial strains tested. However, it showed relatively low or no activity against the Gramnegative bacterial strains.
Because 1 showed excellent activity against all of six Staphylococcus aureus strains, its effectiveness against MRSA was also intensively evaluated. Its MICs against 19 MRSA strains were examined. The ranges of MIC, MIC 50 and MIC 90 for 1 and vancomycin as a positive control are listed in Table 2 . All the strains of MRSA were susceptible to mansonone F and vancomycin. In particular, the antibacterial acitvity of mansonone F against MRSA was comparable to that of vancomycin.
This structurally simple and unique tricyclic ortho-naphthoquinone obviously offers a novel and promising lead as a new anti-MRSA drug prospect. 
